Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks.
Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated